OECD members vs Serbia: Cause of death, by non-communicable diseases, ages 5-14, female
Cause of death, by non-communicable diseases, ages 5-14, female over time
- OECD members
- Serbia
How they compare
Serbia currently reports 83.2% against 57.8% in OECD members, a difference of 25.4%.
That makes Serbia's figure about 1.4 times OECD members's.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was OECD members ahead.
OECD members ranks 3rd and Serbia ranks 3rd of 47 groups.
Across the 3 decades both report, OECD members averaged higher in 1 and Serbia in 2.
Head to head by decade
| Decade | OECD members | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.9% | 51.0% | 0.9% | OECD members |
| 2010s | 59.9% | 70.3% | 10.4% | Serbia |
| 2020s | 58.1% | 77.3% | 19.2% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, OECD members or Serbia?
- Serbia, at 83.2% against 57.8% in OECD members as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between OECD members and Serbia?
- 25.4%, with Serbia ahead.
- How many years of comparable data are there for OECD members and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do OECD members and Serbia rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- OECD members ranks 3rd and Serbia ranks 3rd of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.